Pangaea Oncology, S.A. (BME:PANG)
1.740
0.00 (0.00%)
Sep 16, 2025, 12:00 PM CET
Pangaea Oncology Market Cap
Pangaea Oncology has a market cap or net worth of €59.78 million as of September 16, 2025. Its market cap has increased by 3.82% in one year.
Market Cap
59.78M
Enterprise Value
62.46M
Revenue
14.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.74
Market Cap Chart
Since December 29, 2016, Pangaea Oncology's market cap has increased from 30.03M to 59.78M, an increase of 99.08%. That is a compound annual growth rate of 8.22%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 15, 2025 | 59.78M | -1.69% |
Dec 31, 2024 | 60.81M | 12.24% |
Dec 29, 2023 | 54.18M | 8.35% |
Dec 30, 2022 | 50.00M | 41.34% |
Dec 30, 2021 | 35.38M | 30.94% |
Dec 31, 2020 | 27.02M | -5.88% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Grifols | 7.24B |
Laboratorios Farmaceuticos Rovi | 3.10B |
Almirall | 2.39B |
Pharma Mar | 1.56B |
Faes Farma | 1.34B |
Clínica Baviera | 726.01M |
Laboratorio Reig Jofre | 233.59M |
Prim, S.A. | 215.22M |